JMP Securities Starts Crinetics (CRNX) at Market Outperform
Tweet
Share
E-mailGet Alerts CRNX Hot Sheet
Price: $33.09 +1.47%
Rating Summary:
17 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
17 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
JMP Securities analyst Jonathan Wolleben initiates coverage on Crinetics (NASDAQ: CRNX) with a Market Outperform rating and a price target of $43.00.
For an analyst ratings summary and ratings history on Crinetics click here. For more ratings news on Crinetics click here.
Shares of Crinetics closed at $23.90 yesterday.
You May Also Be Interested In
- Crinetics launches patient advocacy program for endocrine diseases
- Needham Starts Horizon Quantum (HQ) at Buy
- Citi Resumes Sherwin-Williams (SHW) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
